<p><b>A</b>. BITC inhibits migration of BxPC-3 cells. BxPC-3 cells were plated, scratched with pipette tip, and incubated in the absence or presence of 5 µM BITC. Photomicrographs were made at regular intervals using inverted microscope. <b>B</b>. Quantitative representation of migration assay. Wound area in BITC-treated and control cells were quantified by Image J software and presented as mean ± SD of triplicates. p<0.01, statistically significant when compared to corresponding time points in controls cells. <b>C–D</b>. BITC inhibits the invasion of BxPC-3 and PanC-1 cells. Invasion assay was performed using Boyden's chamber. Results are presented as mean ± SD of triplicates. p<0.05, statistically significant when compared controls.</p
<p>(A) Incubation of cells in the absence or presence of 10 µM indirubin or I3M was carried out for ...
<p>(A), Transwell migration assay. AsPC-1 and PANC-1 cells were plated in the top chamber of the tra...
<p>The cell migration and invasion capacity of pancreatic cancer cells treated with conditioned medi...
Transwell assays were performed to assess the migration of (A) S2-013, (B) BxPC-3, (C) MIA PaCa-2, (...
<p>Cells were treated with 10 µM TCP, ChlA, BA, CA, TDI, AMN, MER or ROX for 24 hours. (<b>A</b>) Pe...
<p>(A)Cells were plated onto uncoated plates and after 24 hours the monolayer was scraped with a 10 ...
Intact isolated neutrophils (3.3 × 105 cells/mL) and NETs (300 mg/dL final protein concentration) we...
<p>KP3 and BxPC3 cell lines were treated for 48 h with control (DMSO) and GSI (2.5 µM, 5 µM, 10 µM) ...
<p><b>A</b>) ‘Wound healing’ assay. A confluent layer of L3.6pl was scratched and either left untrea...
<p><b>A</b>. BITC inhibits the secretion of proangiogenic factors from HUVECs. Cells were plated, st...
<p>(A) Wound healing assay was performed to evaluate the migration of PANC-1 and HPAC cells after si...
<p>Migration and invasion assays were performed on Capan1 cells treated with vehicle, 100/ml CXCL1, ...
<p>A) Quantitative analysis of tumor proliferation detected by BrdUrd incorporation; *p<0.003. B) Qu...
<p>The migration of HepG2/C3A and <b>PLC/PRF/5</b> cells was assayed using the Boyden chamber techni...
<p><b>A</b>. BITC suppresses tumor growth <i>in vivo</i>. BxPC-3 xenografts bearing mice (n = 10) we...
<p>(A) Incubation of cells in the absence or presence of 10 µM indirubin or I3M was carried out for ...
<p>(A), Transwell migration assay. AsPC-1 and PANC-1 cells were plated in the top chamber of the tra...
<p>The cell migration and invasion capacity of pancreatic cancer cells treated with conditioned medi...
Transwell assays were performed to assess the migration of (A) S2-013, (B) BxPC-3, (C) MIA PaCa-2, (...
<p>Cells were treated with 10 µM TCP, ChlA, BA, CA, TDI, AMN, MER or ROX for 24 hours. (<b>A</b>) Pe...
<p>(A)Cells were plated onto uncoated plates and after 24 hours the monolayer was scraped with a 10 ...
Intact isolated neutrophils (3.3 × 105 cells/mL) and NETs (300 mg/dL final protein concentration) we...
<p>KP3 and BxPC3 cell lines were treated for 48 h with control (DMSO) and GSI (2.5 µM, 5 µM, 10 µM) ...
<p><b>A</b>) ‘Wound healing’ assay. A confluent layer of L3.6pl was scratched and either left untrea...
<p><b>A</b>. BITC inhibits the secretion of proangiogenic factors from HUVECs. Cells were plated, st...
<p>(A) Wound healing assay was performed to evaluate the migration of PANC-1 and HPAC cells after si...
<p>Migration and invasion assays were performed on Capan1 cells treated with vehicle, 100/ml CXCL1, ...
<p>A) Quantitative analysis of tumor proliferation detected by BrdUrd incorporation; *p<0.003. B) Qu...
<p>The migration of HepG2/C3A and <b>PLC/PRF/5</b> cells was assayed using the Boyden chamber techni...
<p><b>A</b>. BITC suppresses tumor growth <i>in vivo</i>. BxPC-3 xenografts bearing mice (n = 10) we...
<p>(A) Incubation of cells in the absence or presence of 10 µM indirubin or I3M was carried out for ...
<p>(A), Transwell migration assay. AsPC-1 and PANC-1 cells were plated in the top chamber of the tra...
<p>The cell migration and invasion capacity of pancreatic cancer cells treated with conditioned medi...